Humana Inc: Form 10-Q for the period ended Jun 30, 2019
Filed with the SEC on Jul 31, 2019 and accepted by EDGAR at Jul 31, 2019, 13:40 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2019-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2019-04-01 to 2019-06-30 | $16.25bn | us-gaap:Revenues |
| Revenue | 6 months2019-01-01 to 2019-06-30 | $32.35bn | us-gaap:Revenues |
| Selling, general and administrative | 3 months2019-04-01 to 2019-06-30 | $1.70bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2019-01-01 to 2019-06-30 | $3.36bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2019-04-01 to 2019-06-30 | $1.11bn | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2019-01-01 to 2019-06-30 | $1.96bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2019-04-01 to 2019-06-30 | $60.0m | us-gaap:InterestExpense |
| Interest expense | 6 months2019-01-01 to 2019-06-30 | $122.0m | us-gaap:InterestExpense |
| Income tax | 3 months2019-04-01 to 2019-06-30 | $301.0m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2019-01-01 to 2019-06-30 | $484.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2019-04-01 to 2019-06-30 | $940.0m | us-gaap:NetIncomeLoss |
| Net income | 6 months2019-01-01 to 2019-06-30 | $1.51bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2019-04-01 to 2019-06-30 | $6.94 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2019-01-01 to 2019-06-30 | $11.10 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2019-04-01 to 2019-06-30 | $6.96 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2019-01-01 to 2019-06-30 | $11.14 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2019-04-01 to 2019-06-30 | 135,579,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2019-01-01 to 2019-06-30 | 135,770,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2019-01-01 to 2019-06-30 | $2.33bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2019-01-01 to 2019-06-30 | $296.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months2019-01-01 to 2019-06-30 | $142.0m | us-gaap:PaymentsOfDividends |
| Share repurchases | 6 months2019-01-01 to 2019-06-30 | $10.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2019-06-30 | $4.78bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2019-06-30 | $20.16bn | us-gaap:AssetsCurrent |
| Total assets | At period end2019-06-30 | $28.91bn | us-gaap:Assets |
| Current liabilities | At period end2019-06-30 | $11.54bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2019-06-30 | $17.04bn | us-gaap:Liabilities |
| Long-term debt | At period end2019-06-30 | $4.38bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2019-06-30 | $1.35bn | us-gaap:DebtCurrent |
| Shareholders' equity | At period end2019-06-30 | $11.87bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2019-06-30 | 135,089,290 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0000049071-19-000085. Last ingested by Listed: Nov 6, 2026, 14:15 ET. Listed shows no prices and gives no investment advice.